NCT03427476
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
Clinical trial condition
Renal Cell Carcinoma
Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
412 public trials
75 recruiting studies
Renal Cell Carcinoma trial results
NCT02585362
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +49 more
- Locations
-
- Kantonsspital Winterthur Winterthur, Switzerland
NCT03176485
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +48 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
NCT00923520
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +43 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- Hershey Medical Center Hershey, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT01762150
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen university cancer center Guangzhou, Guangdong, China
- Shenyang general hospital of Shenyang military command Shenyang, Liaoning, China
- Xijing Hospital Xi’an, Shanxi, China
Completed
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody
NCT00606632
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- David Geffen School of Medicine, UCLA Los Angeles, California, United States
- Stanford University Medical Center Stanford, California, United States
- H. Lee Moffitt Cancer Center & Research Center Tampa, Florida, United States
- Lahey Clinic Burlington, Massachusetts, United States
NCT03670992
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- Department of Surgery "Pietro Valdoni" Roma, Italy
Completed
CRLX101 Plus Bevacizumab in Advanced RCC
NCT01625936
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT02835833
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
NCT01778933
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States